Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas

Epigenetics

Volumn 6, Issue 7, 2011, Pages 920-927

  Banister, Carolyn E ^a   Koestler, Devin C ^b   Maccani, Matthew A ^a   Padbury, James F ^c   Andres Houseman, E ^b   Marsit, Carmen J ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Development; Dna methylation; Epigenetics; Human; Intrauterine growth restriction; Placenta; Small for gestational age

Indexed keywords

DNA;

ADULT; ARTICLE; BODY MASS; CESAREAN SECTION; DNA METHYLATION; FEMALE; FETUS GROWTH; GENDER; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL SMOKING; MICROARRAY ANALYSIS; PARITY; PLACENTA; SMALL FOR DATE INFANT; SMOKING; VAGINAL DELIVERY;

EID: 79960120705     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.7.16079     Document Type: Article

References (54)

1. Crinnion WJ. Maternal levels of xenobiotics that affect fetal development and childhood health. Altern Med Rev 2009; 14:212-222.
2. Kinsella MT, Monk C. Impact of maternal stress, depression and anxiety on fetal neurobehavioral development. Clin Obstet Gynecol 2009; 52:425-440.
3. Christian P, Stewart CP. Maternal micronutrient deficiency, fetal development and the risk of chronic disease. J Nutr 2010; 140:437-445.
4. Perkins CC, Pivarnik JM, Paneth N, Stein AD. Physical activity and fetal growth during pregnancy. Obstet Gynecol 2007; 109:81-87.
5. Fogleman KA, Herring AH, Kaczor D, Pusek SN, Jo H, Thorp JM. Factors that influence the timing of spontaneous labor at term. J Matern Fetal Neonatal Med 2007; 20:813-817.
6. Silveira PP, Portella AK, Goldani MZ, Barbieri MA. Developmental origins of health and disease (DOHaD). J Pediatr (Rio J) 2007; 83:494-504.
7. Maulik D, Frances Evans J, Ragolia L. Fetal growth restriction: pathogenic mechanisms. Clin Obstet Gynecol 2006; 49:219-227.
8. Burton GJ, Jauniaux E, Charnock-Jones DS. The influence of the intrauterine environment on human placental development. Int J Dev Biol 2010; 54:303-312.
9. Lumey LH, Stein AD, Kahn HS, van der Pal-de Bruin KM, Blauw GJ, Zybert PA, et al. Cohort profile: the Dutch Hunger Winter families study. Int J Epidemiol 2007; 36:1196-1204.
10. Diplas AI, Lambertini L, Lee MJ, Sperling R, Lee YL, Wetmur J, et al. Differential expression of imprinted genes in normal and IUGR human placentas. Epigenetics 2009; 4:235-240.
11. McMinn J, Wei M, Schupf N, Cusmai J, Johnson EB, Smith AC, et al. Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta 2006; 27:540-549.
12. Maccani MA, Marsit CJ. Epigenetics in the placenta. Am J Reprod Immunol 2009; 62:78-89.
13. Rahnama F, Shafiei F, Gluckman PD, Mitchell MD, Lobie PE. Epigenetic regulation of human trophoblastic cell migration and invasion. Endocrinology 2006; 147:5275-5283.
14. Rahnama F, Thompson B, Steiner M, Shafiei F, Lobie PE, Mitchell MD. Epigenetic regulation of E-cadherin controls endometrial receptivity. Endocrinology 2009; 150:1466-1472.
15. Serman L, Vlahovic M, Sijan M, Bulic-Jakus F, Serman A, Sincic N, et al. The impact of 5-azacytidine on placental weight, glycoprotein pattern and proliferating cell nuclear antigen expression in rat placenta. Placenta 2007; 28:803-811.
16. Novakovic B, Sibson M, Ng HK, Manuelpillai U, Rakyan V, Down T, et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 2009; 284:14838-14848.
17. Bourque DK, Avila L, Penaherrera M, von Dadelszen P, Robinson WP. Decreased placental methylation at the H19/IGF2 imprinting control region is associated with normotensive intrauterine growth restriction but not preeclampsia. Placenta 2010; 31:197-202.
18. Tabano S, Colapietro P, Cetin I, Grati FR, Zanutto S, Mando C, et al. Epigenetic modulation of the IGF2/ H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction. Epigenetics 2010; 5:313-324.
19. Koestler DC, Marsit CJ, Christensen BC, Karagas MR, Bueno R, Sugarbaker DJ, et al. Semi-supervised recursively partitioned mixture models for identifying cancer subtypes. Bioinformatics 2010; 26:2578-2585.
20. Bibikova M, Fan JB. GoldenGate assay for DNA methylation profiling. Methods Mol Biol 2009; 507:149-163.
21. Einstein F, Thompson RF, Bhagat TD, Fazzari MJ, Verma A, Barzilai N, et al. Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS One 2010; 5:8887.
22. Guillomot M, Taghouti G, Constant F, Degrelle S, Hue I, Chavatte-Palmer P, et al. Abnormal expression of the imprinted gene Phlda2 in cloned bovine placenta. Placenta 2010; 31:482-90.
23. Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med 2009; 180:462-467.
24. Daelemans C, Ritchie ME, Smits G, Abu-Amero S, Sudbery IM, Forrest MS, et al. High-throughput analysis of candidate imprinted genes and allele-specific gene expression in the human term placenta. BMC Genet 2010; 11:25.
25. Pozharny Y, Lambertini L, Ma Y, Ferrara L, Litton CG, Diplas A, et al. Genomic loss of imprinting in firsttrimester human placenta. Am J Obstet Gynecol 2010; 202:391.
26. Guilleret I, Osterheld MC, Braunschweig R, Gastineau V, Taillens S, Benhattar J. Imprinting of tumorsuppressor genes in human placenta. Epigenetics 2009; 4:62-68.
27. Charalambous M, Cowley M, Geoghegan F, Smith FM, Radford EJ, Marlow BP, et al. Maternallyinherited Grb10 reduces placental size and efficiency. Dev Biol 2010; 337:1-8.
28. Lee K, Shim S, Kang K, Kang J, Park D, Kim S, et al. Global gene expression changes induced in the human placenta during labor. Placenta 2010; 31:698-704.
29. Avila L, Yuen RK, Diego-Alvarez D, Penaherrera MS, Jiang R, Robinson WP. Evaluating DNA methylation and gene expression variability in the human term placenta. Placenta 2010; 31:1070-1077.
30. Liang XH, Zhao ZA, Deng WB, Tian Z, Lei W, Xu X, et al. Estrogen regulates amiloride-binding protein 1 through CCAAT/enhancer-binding protein-beta in mouse uterus during embryo implantation and decidualization. Endocrinology 2010; 151:5007-5016.
31. Fant M, Weisoly DL, Cocchia M, Huber R, Khan S, Lunt T, et al. PLAC1, a trophoblast-specific gene, is expressed throughout pregnancy in the human placenta and modulated by keratinocyte growth factor. Mol Reprod Dev 2002; 63:430-436.
32. Lappas M, Lim R, Riley C, Menon R, Permezel M. Expression and localisation of FoxO3 and FoxO4 in human placenta and fetal membranes. Placenta 2010; 31:1043-1050.
33. Brenkman AB, van den Broek NJ, de Keizer PL, van Gent DC, Burgering BM. The DNA damage repair protein Ku70 interacts with FOXO4 to coordinate a conserved cellular stress response. FASEB J 2010; 24:4271-4280.
34. Petraglia F, Coukos G, Volpe A, Genazzani AR, Vale W. Involvement of placental neurohormones in human parturition. Ann NY Acad Sci 1991; 622:331-340.
35. Yen SS. The placenta as the third brain. J Reprod Med 1994; 39:277-280.
36. Yen SS. Endocrine-metabolic adaptions in pregnancy. In: Yen SS, Jaffe RB, Eds. Reproductive Endocrinology. Philadelphia: WB Saunders 1991; 936-970.
37. Lester BM, Padbury JF. Third pathophysiology of prenatal cocaine exposure. Dev Neurosci 2009; 31:23-35.
38. Power ML, Schulkin J. Functions of corticotropinreleasing hormone in anthropoid primates: from brain to placenta. Am J Hum Biol 2006; 18:431-447.
39. Bajoria R, Babawale M. Ontogeny of endogenous secretion of immunoreactive-thyrotropin releasing hormone by the human placenta. J Clin Endocrinol Metab 1998; 83:4148-4155.
40. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178-186.
41. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009; 5:1000602.
42. Wang HY, Wang RF. Regulatory T cells and cancer. Curr Opin Immunol 2007; 19:217-223.
43. Mulero-Navarro S, Esteller M. Epigenetic biomarkers for human cancer: the time is now. Crit Rev Oncol Hematol 2008; 68:1-11.
44. Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, Christos PJ, et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 2010; 17:13-27.
45. Zimmer EZ, Divon MY. Sonographic diagnosis of IUGR-macrosomia. Clin Obstet Gynecol 1992; 35:172-84.
46. Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003; 3:13.
47. Houseman EA, Ryan LM, Coull BA. Cholesky residuals for assessing normal errors in a linear model with correlated outcomes. J Amer Stat Assoc 2004; 99: 383394.
48. Marsit CJ, Houseman EA, Christensen BC, Gagne L, Wrensch MR, Nelson HH, et al. Identification of methylated genes associated with aggressive bladder cancer. PLoS One 5:12334.
49. Poage GM, Christensen BC, Houseman EA, McClean MD, Wiencke JK, Posner MR, et al. Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted. PLoS One 2010; 5:9651.
50. Houseman EA, Christensen BC, Yeh RF, Marsit CJ, Karagas MR, Wrensch M, et al. Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics 2008; 9:365.
51. Marsit CJ, Christensen BC, Houseman EA, Karagas MR, Wrensch MR, Yeh RF, et al. Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis 2009; 30:416-422.
52. Christensen BC, Houseman EA, Godleski JJ, Marsit CJ, Longacker JL, Roelofs CR, et al. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res 2009; 69:227-234.
53. Christensen BC, Marsit CJ, Houseman EA, Godleski JJ, Longacker JL, Zheng S, et al. Differentiation of lung adenocarcinoma, pleural mesothelioma and nonmalignant pulmonary tissues using DNA methylation profiles. Cancer Res 2009; 69:6315-6321.
54. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102:15545-15550.